Release Date: April 25, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Positive Points
- Colgate-Palmolive Co (CL, Financial) has built flexibility into its plans to navigate the volatile and uncertain market environment of 2025.
- The company is focused on delivering value-added, science-based core innovation, such as the relaunch of Colgate Total and Hill's Science Diet with ActivBiome Technology.
- Colgate-Palmolive Co (CL) has invested approximately $2 billion in its supply chain in the United States over the past five years, enhancing its ability to adapt to changing environments.
- The company has a strong balance sheet with low levels of net debt and plans to drive significant cash flow to fund growth and productivity.
- Colgate-Palmolive Co (CL) has seen strong profit growth in the first quarter despite market volatility, indicating effective management and strategy execution.
Negative Points
- The company faces challenges from weaker consumer demand and macroeconomic uncertainty, impacting volume growth.
- Tariffs announced since January are expected to have an incremental impact of roughly $200 million in 2025, posing a financial challenge.
- There has been a slowdown in category growth, particularly in the US and other global markets, affecting overall sales performance.
- Colgate-Palmolive Co (CL) is experiencing some trade down from super-premium to mid-tier products in North America, indicating consumer price sensitivity.
- The company is exiting private label production, which will be a drag on volume growth in the short term.
Q & A Highlights
Q: Can you provide insights into consumer consumption trends across your categories and expectations for category growth throughout the year?
A: Noel Wallace, CEO, explained that while the year started with slower volume growth due to macroeconomic uncertainties, there are signs of improvement in April. The company expects category growth to normalize towards the back half of the year as consumer confidence returns. Despite the challenges, Colgate-Palmolive remains focused on driving household penetration and brand health to sustain long-term growth.
Q: How is Colgate-Palmolive addressing the impact of tariffs, and what strategies are in place to mitigate these costs?
A: Noel Wallace, CEO, stated that the company expects an incremental impact of $200 million from tariffs in 2025. To mitigate this, Colgate-Palmolive is leveraging supply chain flexibility, alternative sourcing, and revenue growth management. The company has invested significantly in its U.S. supply chain to reduce reliance on single-source countries and is focused on productivity and innovation to offset tariff impacts.
Q: What is the company's approach to pricing in developed and emerging markets, especially in light of tariff headwinds?
A: Noel Wallace, CEO, noted that pricing has decelerated but remains a key strategy, particularly in emerging markets like Latin America. The company is executing pricing adjustments in response to tariff impacts and is focused on premium innovation to drive value. In developed markets, pricing is part of a broader strategy that includes innovation and revenue growth management.
Q: How is the Hill's brand performing, and are there any signs of consumer trade-down within this segment?
A: Noel Wallace, CEO, reported that the Hill's brand is performing well, with no significant trade-down observed. The brand achieved 5% organic growth, driven by strong performance across all product categories, including wet, dry, and treats. The company continues to invest in innovation and capacity expansion to support growth in the Hill's segment.
Q: Can you elaborate on the company's performance in Europe and the role of the Elmex brand in your strategy?
A: Noel Wallace, CEO, highlighted strong performance in Europe, driven by market share gains in oral care, including the Elmex brand. The strategy involves innovation, professional advocacy, and selective market expansion. Elmex's success in Europe is being evaluated for potential expansion into other markets, with a focus on long-term growth.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
